Carl Zeiss Meditec AGXSWX:AFX 79 Current Ratio is 0.00 as of Dec. 2025. GuruFocus rates XSWX:AFX with a GF Score™ of 79/100 and a GF Value™ of CHF67.74 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks worse than 53.63% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Carl Zeiss Meditec AG's current ratio for the quarter that ended in Dec. 2025 was 0.00.
Carl Zeiss Meditec AG has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Carl Zeiss Meditec AG has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Carl Zeiss Meditec AG's Current Ratio or its related term are showing as below:
XSWX:AFX'
s Current Ratio Range Over the Past 10 Years
Min: 2.04 Med: 3.51 Max: 4.71
Current: 2.34
During the past 13 years, Carl Zeiss Meditec AG's highest Current Ratio was 4.71. The lowest was 2.04. And the median was 3.51.
XSWX:AFX's Current Ratio is ranked worse than 53.63% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs XSWX:AFX: 2.34
Carl Zeiss Meditec AG (XSWX:AFX) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Carl Zeiss Meditec AG Current Ratio Related Terms
Carl Zeiss Meditec AG Current Ratio Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:AFX vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (XSWX:AFX) has a Current Ratio of 0.00 as of Dec. 2025. Over the past decade, Carl Zeiss Meditec AG's Current Ratio has ranged from 2.04 to 4.71. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #458 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 53.6%.
Is Carl Zeiss Meditec AG's Current Ratio too high?
Carl Zeiss Meditec AG's current Current Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 2.04 to a high of 4.71. Based on the distribution chart, Carl Zeiss Meditec AG ranks #458 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Carl Zeiss Meditec AG has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #458 out of 854 companies for Current Ratio. This places Carl Zeiss Meditec AG in the lower half of its industry. The industry median Current Ratio is 2.49. Historically, Carl Zeiss Meditec AG's own Current Ratio has ranged from 2.04 to 4.71 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (XSWX:AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF67.74, compared to a current price of CHF24.80 — trading 63.4% below its estimated fair value. The current Current Ratio is 0.00. Carl Zeiss Meditec AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Current Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of CHF24.80 is trading 63.4% below its estimated GF Value™ of CHF67.74.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for XSWX:AFX:
Current Ratio: 0.00
GF Value™: CHF67.74 vs. price of CHF24.80 (63.4% below fair value)
No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
79GF Score
Get the complete analysis for XSWX:AFX
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AFX has been successfully added to your 
